Submit Search
Upload
Summary Of Schedule Y
•
Download as PPT, PDF
•
61 likes
•
26,738 views
L
lekshmilnair
Follow
Report
Share
Report
Share
1 of 10
Download now
Recommended
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
Aakashdeep Raval
this slide tells about schedule Y, Good Clinical Practice, CDSCO, Ethics committee, consent form, Serious Adverse Events and compensation rules
Schedule y
Schedule y
kumargourav40
Schedule y
Schedule y
Malla Reddy College of Pharmacy
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
ICH GCP
ICH GCP
Suman Baishnab
Schedule y
Schedule y
pharmacologyseminars
Schedule Y amended version 2005, I hope this is useful to All Clinical Research Professionals. -Thank You
Schedule Y
Schedule Y
kamalakar ambati
Regulatory framework of India, Acts and Regulations for conduct of clinical trial in India, Schedule Y, approval of new chemical entity and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
Dr. Siddhartha Dutta
complete description of document required for clinical trial
Documentation clinical trial
Documentation clinical trial
ankit sharma
Recommended
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
Aakashdeep Raval
this slide tells about schedule Y, Good Clinical Practice, CDSCO, Ethics committee, consent form, Serious Adverse Events and compensation rules
Schedule y
Schedule y
kumargourav40
Schedule y
Schedule y
Malla Reddy College of Pharmacy
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
ICH GCP
ICH GCP
Suman Baishnab
Schedule y
Schedule y
pharmacologyseminars
Schedule Y amended version 2005, I hope this is useful to All Clinical Research Professionals. -Thank You
Schedule Y
Schedule Y
kamalakar ambati
Regulatory framework of India, Acts and Regulations for conduct of clinical trial in India, Schedule Y, approval of new chemical entity and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
Dr. Siddhartha Dutta
complete description of document required for clinical trial
Documentation clinical trial
Documentation clinical trial
ankit sharma
For better understanding of students. This will give you a detailed explanation of IND APPLICATION. Contact me through comment section if you need any assistance in understating this topic.
Investigational New Drug Application
Investigational New Drug Application
Suhas Reddy C
Introduction to CONTRACT RESEARCH ORGANIZATION, Background, Over all view of CRO Presented by G.Aravind Kumar Department of Industrial Pharmacy
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
Raghavendra institute of pharmaceutical education and research .
institutional review board and independent ethics committee, their composition, functions etc.
institutional review board and independent ethics committee
institutional review board and independent ethics committee
MOHAMMAD ASIM
ICH GCP guidelines
ICH GCP guidelines
ICH GCP guidelines
rx_sonali
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
Rumana Hameed
“CSR is a detailed regulatory document which gives the information about the methods and results (related to efficacy and safety) of a clinical trial. CSRs are created as a part of the process of submitting applications to the Regulatory Authorities for new medical treatments and for its approval. CSRs can be full, abbreviated, synopsis, supplementary, observational etc as per the results and requirements”.
Turacoz - Clinical Study Report
Turacoz - Clinical Study Report
Turacoz Healthcare Solutions
The ppt gives a basic information about ICH-GCP, how it originated , what led to the formation of ICH-GCP guidelines and what are the principles of the guidelines.
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
AbhishekJoshi312
drug development, IND, withdrawl of IND, exemption, IND review,
Investigational new drug (IND)
Investigational new drug (IND)
Manish Rajput
ba be studies
ba be studies
ba be studies
Rohit K.
The International Council on Harmonisation (ICH) defines an institutional review board (IRB) as a group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup. IRBs can also be called independent ethics committees (IECs). An IRB/IEC reviews the appropriateness of the clinical trial protocol as well as the risks and benefits to study participants. It ensures that clinical trial participants are exposed to minimal risk in relation to any benefits that might result from the research. IRB/IEC members should be collectively qualified to review the scientific, medical and ethical aspects of the trial. Per the FDA, an IRB/IEC should have: At least five members. Members with varying backgrounds. At least one member who represents a non-scientific area (a lay member). At least one member who is not affiliated with the institution or the trial site (an independent member). Competent members who are able to review and evaluate the science, medical aspects and ethics of the proposed trial.
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
RAHUL PAL
Overview on Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
Dr. Harisha S
A clinical trial protocol is a comprehensive document that outlines the objectives, design, methodology, procedures, and statistical considerations of a clinical research study. It serves as a detailed blueprint for conducting the trial and provides guidance to the investigators, study staff, ethics committees, and regulatory authorities involved in the study. Here are the key components typically included in a clinical trial protocol
Clinical Trial Protocol
Clinical Trial Protocol
ClinosolIndia
responsibility of an investigator
responsibility of an investigator
drodo2002
A very good detailed presentation on ICH GCP.
ICH GCP
ICH GCP
PAREXEL International Clinical Research
This slide mainly includes Roles and responsibilities of sponsor CRO and Investigator in Ethical conduct of Clinical Research as per ICH GCP Guidelines Required mainly for Regulatory affairs students
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
MOHAMMEDSALEEMJM
Requirements And Guidelines For Permission To Import / or Manufacture of New Drugs For Sale or To Undertake Clinical Trials Schedule Y was introduced under the Drugs and Cosmetics Act 1940, to introduce requirements for countries to get permission for: Importing Manufacturing new drugs Conducting Clinical Trials. Application for permission Clinical Trial Studies in specific population Post marketing surveillance Special studies: BA/BE studies
Schedule Y
Schedule Y
Parul Institute of Pharmacy
IRB/IEC
Institutional review board by akshdeep sharma
Institutional review board by akshdeep sharma
Akshdeep Sharma
GENERAL INFORMATION ON MONITORING OF CLINICAL TRIALS
Monitoring of clinical trials
Monitoring of clinical trials
kattamurilakshmi
An IND is a submission to the food and drug administration (FDA) requesting permission to initiate a clinical study of a new drug product.
Investigational New drug application [INDA]
Investigational New drug application [INDA]
Sagar Savale
investigational new drug application
ind
ind
Rohit K.
The various rules that come under Schedule Y of the Indian Constitution dealing with the manufacture, import and clinical trials of drugs in india
Schedule Y
Schedule Y
Fardan Qadeer
Schedule y
Schedule y
Malla Reddy College of Pharmacy
More Related Content
What's hot
For better understanding of students. This will give you a detailed explanation of IND APPLICATION. Contact me through comment section if you need any assistance in understating this topic.
Investigational New Drug Application
Investigational New Drug Application
Suhas Reddy C
Introduction to CONTRACT RESEARCH ORGANIZATION, Background, Over all view of CRO Presented by G.Aravind Kumar Department of Industrial Pharmacy
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
Raghavendra institute of pharmaceutical education and research .
institutional review board and independent ethics committee, their composition, functions etc.
institutional review board and independent ethics committee
institutional review board and independent ethics committee
MOHAMMAD ASIM
ICH GCP guidelines
ICH GCP guidelines
ICH GCP guidelines
rx_sonali
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
Rumana Hameed
“CSR is a detailed regulatory document which gives the information about the methods and results (related to efficacy and safety) of a clinical trial. CSRs are created as a part of the process of submitting applications to the Regulatory Authorities for new medical treatments and for its approval. CSRs can be full, abbreviated, synopsis, supplementary, observational etc as per the results and requirements”.
Turacoz - Clinical Study Report
Turacoz - Clinical Study Report
Turacoz Healthcare Solutions
The ppt gives a basic information about ICH-GCP, how it originated , what led to the formation of ICH-GCP guidelines and what are the principles of the guidelines.
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
AbhishekJoshi312
drug development, IND, withdrawl of IND, exemption, IND review,
Investigational new drug (IND)
Investigational new drug (IND)
Manish Rajput
ba be studies
ba be studies
ba be studies
Rohit K.
The International Council on Harmonisation (ICH) defines an institutional review board (IRB) as a group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup. IRBs can also be called independent ethics committees (IECs). An IRB/IEC reviews the appropriateness of the clinical trial protocol as well as the risks and benefits to study participants. It ensures that clinical trial participants are exposed to minimal risk in relation to any benefits that might result from the research. IRB/IEC members should be collectively qualified to review the scientific, medical and ethical aspects of the trial. Per the FDA, an IRB/IEC should have: At least five members. Members with varying backgrounds. At least one member who represents a non-scientific area (a lay member). At least one member who is not affiliated with the institution or the trial site (an independent member). Competent members who are able to review and evaluate the science, medical aspects and ethics of the proposed trial.
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
RAHUL PAL
Overview on Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
Dr. Harisha S
A clinical trial protocol is a comprehensive document that outlines the objectives, design, methodology, procedures, and statistical considerations of a clinical research study. It serves as a detailed blueprint for conducting the trial and provides guidance to the investigators, study staff, ethics committees, and regulatory authorities involved in the study. Here are the key components typically included in a clinical trial protocol
Clinical Trial Protocol
Clinical Trial Protocol
ClinosolIndia
responsibility of an investigator
responsibility of an investigator
drodo2002
A very good detailed presentation on ICH GCP.
ICH GCP
ICH GCP
PAREXEL International Clinical Research
This slide mainly includes Roles and responsibilities of sponsor CRO and Investigator in Ethical conduct of Clinical Research as per ICH GCP Guidelines Required mainly for Regulatory affairs students
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
MOHAMMEDSALEEMJM
Requirements And Guidelines For Permission To Import / or Manufacture of New Drugs For Sale or To Undertake Clinical Trials Schedule Y was introduced under the Drugs and Cosmetics Act 1940, to introduce requirements for countries to get permission for: Importing Manufacturing new drugs Conducting Clinical Trials. Application for permission Clinical Trial Studies in specific population Post marketing surveillance Special studies: BA/BE studies
Schedule Y
Schedule Y
Parul Institute of Pharmacy
IRB/IEC
Institutional review board by akshdeep sharma
Institutional review board by akshdeep sharma
Akshdeep Sharma
GENERAL INFORMATION ON MONITORING OF CLINICAL TRIALS
Monitoring of clinical trials
Monitoring of clinical trials
kattamurilakshmi
An IND is a submission to the food and drug administration (FDA) requesting permission to initiate a clinical study of a new drug product.
Investigational New drug application [INDA]
Investigational New drug application [INDA]
Sagar Savale
investigational new drug application
ind
ind
Rohit K.
What's hot
(20)
Investigational New Drug Application
Investigational New Drug Application
CONTRACT RESEARCH ORGANIZATION
CONTRACT RESEARCH ORGANIZATION
institutional review board and independent ethics committee
institutional review board and independent ethics committee
ICH GCP guidelines
ICH GCP guidelines
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
Turacoz - Clinical Study Report
Turacoz - Clinical Study Report
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
Investigational new drug (IND)
Investigational new drug (IND)
ba be studies
ba be studies
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptx
Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
Clinical Trial Protocol
Clinical Trial Protocol
responsibility of an investigator
responsibility of an investigator
ICH GCP
ICH GCP
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
Schedule Y
Schedule Y
Institutional review board by akshdeep sharma
Institutional review board by akshdeep sharma
Monitoring of clinical trials
Monitoring of clinical trials
Investigational New drug application [INDA]
Investigational New drug application [INDA]
ind
ind
Viewers also liked
The various rules that come under Schedule Y of the Indian Constitution dealing with the manufacture, import and clinical trials of drugs in india
Schedule Y
Schedule Y
Fardan Qadeer
Schedule y
Schedule y
Malla Reddy College of Pharmacy
Schedule y -_priti_gupta
Schedule y -_priti_gupta
Priti Gupta
Europian medicines agency
Emea
Emea
Ranjeet Singh
cfr
Code of federal regulations {cfr}
Code of federal regulations {cfr}
Nipun Gupta
full review about cdsco organisation and its approval process...
Cdsco- a regulatory overview
Cdsco- a regulatory overview
Vivekanandan S
Brief description about cdsco, pharmacovigilance programme of India (PvPI) and the process of reporting an ADR in India.
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
kiran pala
REGULATION OF CLINICAL RESEARCH
Schedule y, mk sharma
Schedule y, mk sharma
SHARDA UNIVERSITY
21 CFR PART 11
21 CFR PART 11
Dipak Patel
Schedule Y ( A standard Guidelines for Conduct Clinical Trial in India )
Schedule Y
Schedule Y
Kirti Krishna
Pharmacovigilance full information
Pharmacovigilance full information
Ravindra Kumar
Viewers also liked
(11)
Schedule Y
Schedule Y
Schedule y
Schedule y
Schedule y -_priti_gupta
Schedule y -_priti_gupta
Emea
Emea
Code of federal regulations {cfr}
Code of federal regulations {cfr}
Cdsco- a regulatory overview
Cdsco- a regulatory overview
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
Schedule y, mk sharma
Schedule y, mk sharma
21 CFR PART 11
21 CFR PART 11
Schedule Y
Schedule Y
Pharmacovigilance full information
Pharmacovigilance full information
Similar to Summary Of Schedule Y
Brief summary of Schedule Y
Schedule Y Summary
Schedule Y Summary
Shrinath Sonwane
Schedule y draft 2
Schedule y draft 2
Malla Reddy College of Pharmacy
Schedule Y
Schedule Y by akshdeep sharma
Schedule Y by akshdeep sharma
Akshdeep Sharma
Schedule Y
Seminar schedule 'y'
Seminar schedule 'y'
SameerKhasbage
Schedule y jjjjjjjjjjjjjjjjjjjppt
Schedule y jjjjjjjjjjjjjjjjjjjppt
Malla Reddy College of Pharmacy
summary of schedule Y of drug and cosmetic act.
Schedule Y
Schedule Y
Richa Patel
Schedule-Y
Schedule Y-2019
Schedule Y-2019
Devang Rana
Dr.s.s amended schedule y
Dr.s.s amended schedule y
National Institute of Biologics
SCHEDULE Y
Schedule y
Schedule y
AMRUTHA JOSE
Introduction to Investigational new drug application, New drug application, Abbrevated new drug application
INDA/NDA/ANDA
INDA/NDA/ANDA
Rohit Bhosale
No research without action,no action without research.
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
DilsarGohil1
schedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic acts
arponbiswas
INDA- Investigation New Drug Application, useful presentation for UG and PG students
INDA- Investigation New Drug Application
INDA- Investigation New Drug Application
Dr. Jigar Vyas
introduction to schedule Y under drugs and cosmetic act 1945
Schedule y under drugs and cosmetic act 1945
Schedule y under drugs and cosmetic act 1945
neelotpal31
schedule y
schedule y
pharmacologyseminars
Post marketing surveillance
Post marketing surveillance
Post marketing surveillance
Dhruvi50
Schedule y
Schedule y
Schedule y
Ashishkumar Baheti
Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trial
RGPV BHOPAL
Dcgi adverse event
Dcgi adverse event
Prabir Chatterjee
Unit-II,Chapter 1. Regulatory Approval Process B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory).
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
Audumbar Mali
Similar to Summary Of Schedule Y
(20)
Schedule Y Summary
Schedule Y Summary
Schedule y draft 2
Schedule y draft 2
Schedule Y by akshdeep sharma
Schedule Y by akshdeep sharma
Seminar schedule 'y'
Seminar schedule 'y'
Schedule y jjjjjjjjjjjjjjjjjjjppt
Schedule y jjjjjjjjjjjjjjjjjjjppt
Schedule Y
Schedule Y
Schedule Y-2019
Schedule Y-2019
Dr.s.s amended schedule y
Dr.s.s amended schedule y
Schedule y
Schedule y
INDA/NDA/ANDA
INDA/NDA/ANDA
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
schedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic acts
INDA- Investigation New Drug Application
INDA- Investigation New Drug Application
Schedule y under drugs and cosmetic act 1945
Schedule y under drugs and cosmetic act 1945
schedule y
schedule y
Post marketing surveillance
Post marketing surveillance
Schedule y
Schedule y
Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trial
Dcgi adverse event
Dcgi adverse event
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
Summary Of Schedule Y
1.
SUMMARY OF SCHEDULE
Y By Lekshmi.L.Nair
2.
3.
4.
5.
6.
7.
8.
9.
10.
Download now
![What is schedule y? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)